Michaëla Semeraro
0009-0005-7255-1922
Publication & Citation Trends
Publications
93 total
Primary and Safety Outcomes of a Phase 3 Open-Label, Single-Arm, 12-Week Study of Treatment with PI3Kδ Inhibitor Leniolisib in Pediatric Patients Aged 4–11 Years with Activated PI3Kδ Syndrome (APDS)
Cited by 0
Semantic Scholar
Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patients. OA
Cited by 11
Semantic Scholar
Analysis of the impact of the SARS-CoV-2 infection on the pediatric population hospitalized during the pandemic in the Greater Paris University Hospitals OA
Cited by 0
Semantic Scholar
Pediatric Tumors and Developmental Anomalies: A French Nationwide Cohort Study. OA
Cited by 4
Semantic Scholar
Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity. OA
Cited by 46
Semantic Scholar
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy OA
Cited by 17
Semantic Scholar
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome OA
Cited by 0
Semantic Scholar
Saliva for molecular detection of SARS‐CoV‐2 in pre‐school and school‐age children OA
Cited by 3
Semantic Scholar
Research Topics
Immune Cell Function and Interaction
(16)
Hemoglobinopathies and Related Disorders
(12)
Cancer Immunotherapy and Biomarkers
(11)
Neuroblastoma Research and Treatments
(9)
Gastrointestinal Tumor Research and Treatment
(7)
Affiliations
Université Paris-Sud
Délégation Paris 5
University of Parma
Hôpital Necker-Enfants Malades
Centre National de la Recherche Scientifique